Clinical Trials Sponsored by Acorai AB

Total 1107 results

BioGaia AB

Completed

Double-blinded, Randomized, Placebo-controlled Study Evaluating the Effect of the Probiotic on Recurrent Urinary Tract Infection

Recurrent Urinary Tract Infection in Adult Women

Sweden
AB Science

Completed

Masitinib in the Treatment of Patients With Severe Uncontrolled Asthma and Elevated Eosinophil Levels

Asthma

Malaysia, Argentina, Peru, Philippines, Ukraine
AB Science

Completed

Masitinib in Combination With FOLFIRI in Third or Fourth Line of Treatment of Patients With Metastatic Colorectal Cancer

Colorectal Cancer Metastatic

Czechia, France, Russian Federation, Spain, United Kingdom
AB Science

Completed

Masitinib in Combination With Gemcitabine in Advanced/Metastatic Epithelial Ovarian Cancer Patients

Ovarian Cancer

France, United Kingdom, Ukraine, Algeria, Russian Federation, Spain
Enzymatica AB

Completed

Evaluation of ColdZyme® Mouth Spray on Prevention and Alleviation of Rhinovirus Induced Common Cold (COLDPREV)

Common Cold
AB Science

Terminated

Masitinib in Non-Resectable or Metastatic Stage 3/4 Melanoma Carrying a Mutation in the Juxta Membrane Domain of c-Kit

Metastatic Melanoma

France, Spain, Italy, United States, Czechia, Germany, Russian Federation
Dilafor AB

Completed

Effect of Tafoxiparin to Treat Primary Slow Progress of Labor Including Prolonged Latent Phase and Labor Arrest

Labor, Obstetric

Finland, Sweden, Denmark
AB Science

Completed

Efficacy and Safety of Masitinib in the Treatment of Progressive Multiple Sclerosis

Multiple Sclerosis, Secondary Progressive | Multiple Sclerosis, Primary Progressive | Multiple Sclerosis, Relapse Free

Poland, Spain, Bulgaria, France, Germany, Greece, Romania
Probi AB

Terminated

Probiotics in Radiation-treated Gynecologic Cancer (ProRad)

Gynecologic Cancer | Gastrointestinal Toxicity

Sweden
Probi AB

Completed

Efficacy of Probiotics on Iron Status During Pregnancy

Prevention of Iron Deficiency

Sweden
AB Science

Terminated

Masitinib in First Line Treatment of Gastro-Intestinal Stromal Tumor (GIST)

Gastrointestinal Stromal Tumors

United States, France, Lebanon
AB Science

Completed

Masitinib in Relapse or Refractory Multiple Myeloma With t(4/14) Translocation Expressing or Not FGFR3

Multiple Myeloma

France
Enzymatica AB

Completed

Duration of ColdZyme® II

Common Cold

Iceland
Triomed AB

Completed

A Performance Analysis of the Peritoneal Ultrafiltration (PUF) Achieved With the Carry Life® UF

Chronic Renal Failure

Sweden
Aventure AB

Completed

Evaluation of Postprandial Glycaemia in a Healthy Population After Intake of Milk and Oat Based Products

Healthy

Sweden
Probi AB

Completed

Efficacy of Probiotics on Physical Performance

Physical Performance

Sweden
Probi AB

Completed

Probiotic Intervention for Acute Stress

Stress

Sweden
AB Science

Terminated

Masitinib in Combination With FOLFIRI for Second-line Treatment of Patients With Metastatic Colorectal Cancer

Metastatic Colorectal Cancer

France, Singapore, United Kingdom
Cortendo AB

Completed

Levoketoconazole Food Effect Study in Healthy Subjects

Healthy Subjects

United States
AB Science

Terminated

Masitinib in Refractory Active Rheumatoid Arthritis

Rheumatoid Arthritis (RA)

Czechia
AB Science

Completed

Efficacy of Oral AB1010 in Adult Patients With Severe Persistent Corticosteroid Dependent Asthma

Asthma
AB Science

Completed

Masitinib in Patients With Gastro-Intestinal Stromal Tumour Resistant to Imatinib

Gastro Intestinal Stromal Tumor

France
AB Science

Completed

A Double-blind, Placebo-controlled, Randomized, Parallel-group Study to Evaluate the Activity of Oral AB1010 in Adults Patients With Moderate to Severe Chronic Plaque Psoriasis

Psoriasis
AB Science

Completed

Masitinib in Patients With Mastocytosis With Handicap and Bearing the D816V Mutation

Mastocytosis
Probi AB

Completed

Efficacy of a Probiotic Product in Children With Antibiotic-associated Gastrointestinal Disorders

Antibiotic-associated Diarrhea

Poland
Probi AB

Completed

Efficacy of a Probiotic Product on Bone Mineral Density (BMD) in Healthy Women in Early Post-menopausal Phase (ProBone16)

Osteopenia

Sweden
Camurus AB

Completed

Phase II Study of Subcutaneous Injection Depot of Leuprolide Acetate in Patient With Prostate Cancer

Prostate Cancer

Finland, Hungary
Orexo AB

Terminated

Conversion From Fast Acting Oral Opioids to Abstral®

Pain

Sweden
Probi AB

Terminated

Benefit and Tolerability of a Probiotic Product in Infants With Abdominal Discomfort

Abdominal Discomfort

Germany
Immunsystem AB

Completed

Anti-pseudomonas IgY to Prevent Infections in Cystic Fibrosis (PseudIgY)

Cystic Fibrosis | Infection | Pseudomonas Aeruginosa

Sweden
Bactiguard AB

Completed

BIP ETT Clinical Tolerability, Safety and Performance Study (BIPETT)

Hospital Acquired Infections | Endotracheal Intubation During Surgery

Sweden
Axelar AB

Completed

A Study to Assess the Effect of Food on the Bioavailability of the IGF-1R Inhibitor AXL1717 in Patients With Advanced Malignant Tumors

Solid Tumors | Hematological Malignancies

Sweden
SciBase AB

Completed

SciBase International Melanoma Pivotal Study

Malignant Melanoma

United States, Sweden
Axelar AB

Completed

Study of AXL1717 Compared to Docetaxel to Treat Squamous Cell Carcinoma or Adenocarcinoma of the Lung

Non-small-cell Lung Cancer | Squamous Cell Carcinoma | Adenocarcinoma of the Lung

Russian Federation, Ukraine, Belarus, Hungary, Poland
Axelar AB

Completed

A Study of the IGF-1R Inhibitor AXL1717 in Combination With Gemcitabine HCL and Carboplatin to Treat Non-small-cell Lung Cancer (NSCLC)

Non Small Cell Lung Cancer

Sweden
AB Foundation

Completed

Miltefosine to Treat Cutaneous Leishmaniasis in Bolivia

Cutaneous Leishmaniasis

Bolivia
PharmaSurgics AB

Completed

Safety Study Investigating Local Tolerability and Pharmacokinetics of PXL01 in Healthy Volunteers

Post-surgery Adhesion Formation

Sweden
Biolipox AB

Completed

Taste and Local Tolerance Study of NLA Nasal Spray in Patients With Allergic Rhinitis

Allergic Rhinitis

Sweden
Acorda Therapeutics

Completed

Safety and Efficacy of Oral Fampridine-SR for the Treatment of Spasticity Resulting From Spinal Cord Injury

Muscle Spasticity | Spinal Cord Injury

United States, Canada
Acorda Therapeutics

Completed

Pharmacokinetic Study of CVT-301 (Levodopa Inhalation Powder)

Parkinson's Disease

United States
Acorda Therapeutics

Completed

A Study to Evaluate the Efficacy and Safety of Two Dose Strengths of Dalfampridine Extended Release Tablets. (MILESTONE℠)

Post-Ischemic Stroke

United States, Canada
Acorda Therapeutics

Completed

A Study to Compare Two Dose Strengths of CVT-301 (Levodopa Inhalation Powder) With an Oral Dose of Sinemet® (Carbidopa-levodopa) Tablets

Parkinson Disease

United States
Acorda Therapeutics

Completed

A Double-Blind Pharmacokinetic Interaction Study Evaluating the Effect of a Single IV Infusion of GGF2 or Placebo on Midazolam Pharmacokinetics in Patients With Heart Failure

Heart Failure

United States
Acorda Therapeutics

Completed

Safety and Pharmacokinetics (PK) Study of Single Ascending Doses of CVT-427 (Zolmitriptan Inhalation Powder) In Healthy Adults

Migraine

United States
Acorda Therapeutics

Completed

Study of Fampridine-SR Tablets in Multiple Sclerosis Patients

Multiple Sclerosis

United States, Canada
Acorda Therapeutics

Completed

Open-Label Extension Study to Evaluate the Safety, Tolerability and Activity of Oral Fampridine-SR Tablets in Multiple Sclerosis Patients Who Participated in the MS-F203 Trial

Multiple Sclerosis

United States, Canada
Lument AB
Q Clinical Research AB

Completed

A Healthy Volunteer Trial Investigating MR-enterography Image Quality of Lumentin® 44

Healthy

Sweden
PepTonic Medical AB
A+ Science AB

Completed

An Efficacy Study of Vagitocin in Postmenopausal Women With Symptoms of Vaginal Atrophy

Atrophy

Sweden
Acorda Therapeutics

Terminated

Bioavailability, Safety and Tolerability of Diazepam Nasal Spray Versus Diazepam Rectal Gel (Diastat®)

Refractory Epilepsy

United States
Acorda Therapeutics

Completed

Study of Oral Fampridine-SR in Multiple Sclerosis

Multiple Sclerosis

United States, Canada

3

Subscribe